Last reviewed · How we verify

NCT03838471

Cognitive Behavioral Factors and Central Sensitization in Chronic Shoulder Pain

Completed Last updated 17 September 2019
What this trial tests

trial in Chronic Shoulder Pain in 64 participants. Completed in 25 March 2019.

Timeline
1 December 2018
Primary endpoint
18 February 2019
25 March 2019

Quick facts

Lead sponsorTechnological Education Institute of Sterea Ellada
StatusCompleted
Study typeOBSERVATIONAL
Enrollment64
Start date1 December 2018
Primary completion18 February 2019
Estimated completion25 March 2019
Sites1 location across Greece

Conditions studied

Sponsor

Technological Education Institute of Sterea Ellada

Who can join

Adults 18 to 80, any sex, with Chronic Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to examine the relationship between symptoms of central sensitization (CS) and important cognitive behavioral and psychosocial factors in patients with chronic shoulder pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. In the Shoulder or in the Brain? Behavioral, Psychosocial and Cognitive Characteristics of Unilateral Chronic Shoulder Pain with Symptoms of Central Sensitization.
    Bilika P, Nijs J, Fandridis E, Dimitriadis Z, et al · · 2022 · cited 21× · PMID 36141270 · DOI 10.3390/healthcare10091658

Verify or expand the search:

Other recruiting trials for Chronic Shoulder Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03838471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing